Trial Profile
A Randomized, Positive-controlled, Single-dose, Dose-escalation Phase I Trial to Evaluate Safety, Tolerability and Explore the Pharmacokinetics and Pharmacodynamics Profile of Pegylated rhEPO in Male Healthy Individual
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Oct 2021
Price :
$35
*
At a glance
- Drugs Erythropoietin (Primary)
- Indications Anaemia
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Xiamen Amoytop Biotech
- 28 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov
- 04 Apr 2014 New trial record